4 - Keros Therapeutics, Inc.

Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001221590-26-000005

Filing Date: 2026-04-17

Accepted: 2026-04-17 16:15:09

Documents: 1

Period of Report: 2026-04-15

BIENAIME JEAN JACQUES ( Reporting ) CIK : 0001221590 (see all company filings) Type: 4 | Act: 34 | File No.: 001-39264 | Film No.: 26871727

1 | form4-04172026_040401.xml | 4 | 4005